|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Real estate, at cost: | ||||||||||||||||||||
| Land | ||||||||||||||||||||
| Buildings and improvements | ||||||||||||||||||||
| Total real estate, at cost | ||||||||||||||||||||
| Less accumulated depreciation | ||||||||||||||||||||
| Property under development | ||||||||||||||||||||
| Real estate held for investment, net | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Mortgage loans receivable, net | ||||||||||||||||||||
| Cash, cash equivalents, and restricted cash | ||||||||||||||||||||
| Lease intangible assets, net | ||||||||||||||||||||
| Other assets, net | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and equity | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Term loans, net | ||||||||||||||||||||
| Revolving credit facility | ||||||||||||||||||||
| Mortgage note payable, net | ||||||||||||||||||||
| Lease intangible liabilities, net | ||||||||||||||||||||
| Liabilities related to assets held for sale | ||||||||||||||||||||
| Accounts payable, accrued expenses, and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| Stockholders’ equity | ||||||||||||||||||||
| Common stock, $0.01 par value, 400,000,000 shares authorized; 125,632,968 and 93,070,533 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Distributions in excess of retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity |
Loading...
